Results 21 to 30 of about 205 (151)

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN‐2.

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Alessandro Matte’   +9 more
wiley   +1 more source

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE

open access: yesРациональная фармакотерапия в кардиологии, 2015
Issues of pathogenesis of the calcified aortic stenosis and ischemic heart disease in the elderly are considered. The relevance of early detection of angina, syncope, and dyspnea in view of their non-specific and subclinical course for early detection of
N. Yu. Karpova   +4 more
doaj   +3 more sources

Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction

open access: yesКардиоваскулярная терапия и профилактика, 2012
Aim. To study the effects of mildronate, as a component of complex therapy, on left ventricular (LV) systolic and diastolic function and exercise capacity (EC) in myocardial infarction (MI) patients undergoing post-hospital rehabilitation.
V. P. Mikhin, O. N. Koltsova
doaj   +1 more source

Antioxidant activity of alkoxy derivatives of (quinoline-4-ylthio)carboxylic acids [PDF]

open access: yesThe Ukrainian Biochemical Journal, 2015
A selection of potential bioactive molecules including alkoxy derivatives of (quinoline-4-ylthio)carboxylic acids using virtual screening has been carried out and their biological activity was determined.
O. О. Brazhko   +4 more
doaj   +1 more source

Phytochemical Analysis, Antioxidant Activity, Antimicrobial Activity, and Cytotoxicity of Chaptalia nutans Leaves

open access: yesAdvances in Pharmacological and Pharmaceutical Sciences, Volume 2020, Issue 1, 2020., 2020
Context. Chaptalia nutans (L.) Pol. (family: Asteraceae) is widely used in traditional medicine as laxative and anticough medications and especially in the traumatisms, wounds, and hemorrhages in topical preparations. Objective. This work was to evaluate the chemical constitution of the hydromethanolic (30/70 methanol‐water) macerating extract obtained
Letiele Bruck de Souza   +9 more
wiley   +1 more source

EFFECTIVENESS OF MELDONIUMIN IN CHRONIC HEART FAILURE PATIENTS

open access: yesМедицинский совет, 2017
This article discusses the relevance of the high mortality of cardiovascular diseases (CVD) and their complications. Provides an overview of research conducted in the field of treatment of chronic heart failure and other cardiovascular diseases.
G. N. Gorokhovskaya   +4 more
doaj   +1 more source

ЦИТОПРОТЕКЦИЯ В КАРДИОЛОГИИ: ДОСТИГНУТЫЕ УСПЕХИ И ПЕРСПЕКТИВЫ. Часть 1

open access: yesАрхивъ внутренней медицины, 2014
The article is devoted to a new direction in medical treatment of ischemic heart disease and arterial hypertension –– the use of cytoprotective and antioxidant agents.
В. П. Михин
doaj   +1 more source

ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY OF MELDONIUM IN IHD PATIENTS WITH STABLE ANGINA

open access: yesМедицинский совет, 2016
(IHD), stable angina of effort of functional class II (43 persons) – III (39 persons) (53.3±7.5 y.o., men - 71, women - 11), with concomitant arterial hypertension – in 21 patient.
V. P. MIKHIN, P. Y. TYURIKOV
doaj   +1 more source

MILDRONATE POTENTIAL FOR CARDIAC ARRHYTHMIA PREVENTION IN PERIOPERATIVE PERIODcardiac arrhythmias, ischemia, metabolic disturbances, cytoprotectors, antioxidants, operation-related stress, general anesthesia, Mildronate

open access: yesКардиоваскулярная терапия и профилактика, 2014
Aim. To assess the effectiveness of Mildronate in the prevention of arrhythmias during the perioperative period of open cholecystectomy under intravenous multicomponent anesthesia.Material and methods.
V. P. Mikhin   +3 more
doaj   +1 more source

METABOLIC MYOCARDIAL CYTOPROTECTORS IN THERAPY OF STABLE ISCHEMIC HEART DISEASE: EVIDENCE OF EFFECTIVENESS AND USE RECOMMENDATIONS

open access: yesМедицинский совет, 2017
The review describes mechanisms of action of metabolic myocardial cytoprotectors and recommendations on their use within the pharmacotherapy of stable ischemic heart disease.
N. B. Perepech
doaj   +1 more source

Home - About - Disclaimer - Privacy